In this CME accredited online course, you will hear from international experts about treatment of PN caused by NF1 with a special focus on MEK inhibitors. 

Learning Objectives:

• MEK inhibitors in children, adolescents and young adult with PN: results of clinical trials and real world experience.
• Identifying candidates for MEK inhibitors: who and when? 
• Is there a minimum age for MEK inhibition? 
• How long should we treat, potential for alternative schedules? 
• Managing side effects of MEK inhibitors. 

Disclaimer:
SIOP accepts that the content on this page meets the essential criterion of non-promotional intent and that it is of educational and scientific relevance to the SIOP target audience.

Supported by an unrestricted educational grant from AstraZeneca.